chlorzoxazone

Generic: chlorzoxazone

Labeler: lifsa drugs llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name chlorzoxazone
Generic Name chlorzoxazone
Labeler lifsa drugs llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

chlorzoxazone 250 mg/1

Manufacturer
Lifsa Drugs LLC

Identifiers & Regulatory

Product NDC 72336-225
Product ID 72336-225_b0267d20-0ac1-4809-a0d4-e8e8eb3f9127
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214702
Listing Expiration 2026-12-31
Marketing Start 2025-03-20

Pharmacologic Class

Established (EPC)
muscle relaxant [epc]
Physiologic Effect
centrally-mediated muscle relaxation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72336225
Hyphenated Format 72336-225

Supplemental Identifiers

RxCUI
197501
UPC
0372336225601
UNII
H0DE420U8G
NUI
N0000175730 N0000175737

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name chlorzoxazone (source: ndc)
Generic Name chlorzoxazone (source: ndc)
Application Number ANDA214702 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (72336-225-60)
source: ndc

Packages (1)

72336-225-60 60 TABLET in 1 BOTTLE (72336-225-60)

Ingredients (1)

chlorzoxazone (250 mg/1)

Linked Drug Pages (1)

Chlorzoxazone ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "b0267d20-0ac1-4809-a0d4-e8e8eb3f9127", "openfda": {"nui": ["N0000175730", "N0000175737"], "upc": ["0372336225601"], "unii": ["H0DE420U8G"], "rxcui": ["197501"], "spl_set_id": ["0f222059-1ece-44f3-ae7f-d277e5bcaba4"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "manufacturer_name": ["Lifsa Drugs LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (72336-225-60)", "package_ndc": "72336-225-60", "marketing_start_date": "20250320"}], "brand_name": "Chlorzoxazone", "product_id": "72336-225_b0267d20-0ac1-4809-a0d4-e8e8eb3f9127", "dosage_form": "TABLET", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "72336-225", "generic_name": "Chlorzoxazone", "labeler_name": "Lifsa Drugs LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Chlorzoxazone", "active_ingredients": [{"name": "CHLORZOXAZONE", "strength": "250 mg/1"}], "application_number": "ANDA214702", "marketing_category": "ANDA", "marketing_start_date": "20250320", "listing_expiration_date": "20261231"}